ScoreWhy is BrightGene Bio-Medical Technology Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 14.19% and Operating profit at -10.35% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.15% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 14.19% and Operating profit at -10.35% over the last 5 years
3
The company has declared negative results for the last 6 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 189.91 MM
- PRE-TAX PROFIT(Q) At CNY -12.51 MM has Fallen at -129.09%
- ROCE(HY) Lowest at 5.6%
4
With ROE of 2.57%, it has a very expensive valuation with a 12.64 Price to Book Value
- Over the past year, while the stock has generated a return of 58.03%, its profits have fallen by -60.5%
- At the current price, the company has a high dividend yield of 0.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BrightGene Bio-Medical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
BrightGene Bio-Medical Technology Co., Ltd.
-100.0%
0.84
59.45%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.19%
EBIT Growth (5y)
-10.35%
EBIT to Interest (avg)
25.45
Debt to EBITDA (avg)
3.56
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
0.26
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
21.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.70%
ROE (avg)
9.15%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
492
Industry P/E
Price to Book Value
12.64
EV to EBIT
390.25
EV to EBITDA
141.48
EV to Capital Employed
8.06
EV to Sales
28.55
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
2.07%
ROE (Latest)
2.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 4.18%
-37What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 189.91 MM
PRE-TAX PROFIT(Q)
At CNY -12.51 MM has Fallen at -129.09%
ROCE(HY)
Lowest at 5.6%
RAW MATERIAL COST(Y)
Grown by 20.27% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.63%
NET SALES(Q)
Lowest at CNY 246.27 MM
INTEREST(Q)
Highest at CNY 14.97 MM
OPERATING PROFIT(Q)
Lowest at CNY -9.35 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -3.79 %
NET PROFIT(Q)
Lowest at CNY 11.24 MM
Here's what is working for BrightGene Bio-Medical Technology Co., Ltd.
Debtors Turnover Ratio
Highest at 4.18%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for BrightGene Bio-Medical Technology Co., Ltd.
Net Sales
At CNY 246.27 MM has Fallen at -22.69%
over average net sales of the previous four periods of CNY 318.53 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -12.51 MM has Fallen at -129.09%
over average net sales of the previous four periods of CNY 43.02 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 11.24 MM has Fallen at -76.95%
over average net sales of the previous four periods of CNY 48.75 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 189.91 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
At CNY 14.97 MM has Grown at 16.5%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 246.27 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Interest
Highest at CNY 14.97 MM
in the last five periods and Increased by 16.5% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY -9.35 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -3.79 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -12.51 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 11.24 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 1.63%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 20.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
